# Eastern Ablation Registry for Solid Tumor (EAST)

> **NCT03362749** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Solid Tumor Including Thyroid, Bone, Liver, Pancreas

## Interventions

- **OTHER:** RFA, MWA, cryo and IRE

## Key facts

- **NCT ID:** NCT03362749
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03362749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03362749, "Eastern Ablation Registry for Solid Tumor (EAST)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03362749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*